MARKET
IPO

SCAN

Perspectum Group Ltd
SCAN
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-850.00~-750.00
-
-
553.39M~627.17M
Advanced Medical Equipment & Technology
2021-06-25
Public Filing
View Prospectus
Pending
Offering
Price Range: 15.00~17.00
Shares to be Issued: 4687.50K
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 36.89M
Listed
No Data
About SCAN
Perspectum Group Ltd. is a United Kingdom-based company engaged in the field of precision health technology and delivering advanced solutions to health care providers. The Company’s products include LiverMultiScan, MRCP+, CoverScan and Hepatica. Its LiverMultiScan is for non-invasive diagnosis and monitoring of liver disorders. MRCP+ product is a noninvasive diagnostic tool for visualization and quantitative assessment of the biliary system. The CoverScan product is a noninvasive imaging solution for the quantitative assessment of six different organs. Hepatica product is a noninvasive clinical and surgical decision support tool to help physicians assess liver health and volume. The Company’s software products consist of image formation, magnetic resonance image (MRI) analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer.

Webull offers Perspectum Group Ltd stock information, including NASDAQ: SCAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCAN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCAN stock methods without spending real money on the virtual paper trading platform.